Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Andrew Makin Preclinical Consulting ApS
APS
Active
CVR 40625240
Hvedevænget 35
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2019
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 830K
-40% vs 2024
EBITDA margin
30.9%
-60% vs 2024
Equity ratio
69.9%
Financial strength
Net profit 2025
DKK 198K
-60% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
DKK 830K
-40%
EBITDA
DKK 257K
-60%
Net profit
DKK 198K
-60%
Total assets
DKK 757K
-31%
Equity
DKK 529K
-32%
Employees
2
—
Company information
Legal name
Andrew Makin Preclinical Consulting ApS
CVR number
40625240
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
1. juli 2019
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er konsulentydelser inden for præklinisk forskning og udvikling af lægemidler.
Contact
Address
Hvedevænget 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Fredensborg
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
1M
2023
1M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.516
1.561
1.353
1.376
830
Staff expenses
-923
-1.005
-772
-739
-573
EBITDA
593
556
581
638
257
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
593
556
581
638
257
Net financials
-7
-7
-5
-7
-3
Profit before tax
586
549
576
630
254
Tax
130
121
127
139
56
Net profit
456
428
449
492
198
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
858
1.011
1.142
1.098
757
Equity
549
668
690
781
529
Long-term debt
0
0
0
0
0
Short-term debt
309
343
452
317
228
Total debt
309
343
452
317
228
Financial ratios
5-year trend
EBITDA margin
30.9%
This company
15.8%
Market median
+96% vs market
2021
2025
Equity ratio
69.9%
This company
38.2%
Market median
+83% vs market
2021
2025
Return on equity
37.4%
This company
18.4%
Market median
+103% vs market
2021
2025
Net profit margin
23.9%
This company
8.1%
Market median
+195% vs market
2021
2025
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
2021
2025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AM
Andrew Makin
Management
Management
2019
UF
Ulrik Fleischer-Michaelsen
Founder
Founder
2019
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Andrew Makin Holdings ApS
Company
100%
100%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Andrew Makin Holdings ApS
Andrew Makin Preclinical Consulting ApS
(this company)
Board network connections
Board members of Andrew Makin Preclinical Consulting ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Andrew Makin
Management
0 companies
Ulrik Fleischer-Michaelsen
Founder
0 companies